Literature DB >> 5469787

Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.

R A O'Reilly, G Levy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5469787     DOI: 10.1002/jps.2600590909

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  8 in total

1.  Proceedings: Interaction of carbenoxolone sodium with other drigs bound to plasma proteins.

Authors:  S Gottfried; D V Parke; P J Sacra; P C Thornton
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Studies of the interaction of carbenoxolone sodium and warfarin sodiun in vivo [proceedings].

Authors:  S Gottfried; D V Parke; P J Sacra; P C Thornton
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Individual variation in the response to phenprocoumon.

Authors:  S Husted; F Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1977       Impact factor: 2.953

4.  Pharmacokinetic consequences of drug displacement from blood and tissue proteins.

Authors:  J J MacKichan
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

5.  Displacement of phenprocoumon (Marcumar) from albumin by sulfonylurea compounds, suramin, and ioglycamic acid.

Authors:  B Hüthwohl; E Jähnchen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

6.  Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.

Authors:  R A O'Reilly; W F Trager; C H Motley; W Howald
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

7.  Interaction of phenylbutazone with racemic phenprocoumon and its enantiomers in rats.

Authors:  W Schmidt; E Jähnchen
Journal:  J Pharmacokinet Biopharm       Date:  1979-12

8.  Binding of non-steroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro.

Authors:  C Tesseromatis; B Fichtl; H Kurz
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.